Clinical Trial Update: Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease [NA]

View source ↗

Summary

This ClinicalTrials.gov entry describes a study aimed at optimizing noninvasive assessment of dysmetabolic compensated advanced liver disease in patients with N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: NASH, NAFLD | NA | Status: RECRUITING